Literature DB >> 19237703

An inverse association of cardiovascular risk and frontal lobe glucose metabolism.

B Kuczynski1, W Jagust, H C Chui, B Reed.   

Abstract

OBJECTIVE: To investigate associations between vascular risk profile and cerebral glucose metabolism.
METHODS: Subjects ranged from normal to having dementia (age >55 years) and underwent neuropsychological testing, MRI, and FDG PET scanning (n = 58). The Framingham Cardiovascular Risk Profile (FCRP) and its individual components were used as covariates in regression analyses with each PET scan using SPM2.
RESULTS: Analyses revealed broad areas of the frontal lobe in which higher FCRP was associated with lower normalized glucose metabolism including the superior medial frontal, superior frontal and superior orbital frontal cortex and the ventrolateral prefrontal cortex. Significant associations were predominately found in the left hemisphere. Independent component analyses revealed interesting regions but further confirm the relevance of the integrative measure of coronary risk.
CONCLUSIONS: Although the mechanism of this association bears further investigation, this finding provides further evidence that vascular risk factors have malignant effects on the brain, particularly in the prefrontal cortex.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19237703      PMCID: PMC2677543          DOI: 10.1212/01.wnl.0000343005.35498.e5

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  40 in total

1.  Resting state glucose utilization and the CERAD cognitive battery in patients with Alzheimer's disease.

Authors:  S J Teipel; F Willoch; K Ishii; K Bürger; A Drzezga; R Engel; P Bartenstein; H-J Möller; M Schwaiger; H Hampel
Journal:  Neurobiol Aging       Date:  2006-05       Impact factor: 4.673

2.  Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability.

Authors:  H C Chui; W Mack; J E Jackson; D Mungas; B R Reed; J Tinklenberg; F L Chang; K Skinner; C Tasaki; W J Jagust
Journal:  Arch Neurol       Date:  2000-02

3.  Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation.

Authors:  S Minoshima; N L Foster; A A Sima; K A Frey; R L Albin; D E Kuhl
Journal:  Ann Neurol       Date:  2001-09       Impact factor: 10.422

4.  Functional MR imaging in Alzheimer's disease during memory encoding.

Authors:  S A Rombouts; F Barkhof; D J Veltman; W C Machielsen; M P Witter; M A Bierlaagh; R H Lazeron; J Valk; P Scheltens
Journal:  AJNR Am J Neuroradiol       Date:  2000 Nov-Dec       Impact factor: 3.825

5.  Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits.

Authors:  Daniel H S Silverman; Sanjiv S Gambhir; Hsuan-Wen C Huang; Judy Schwimmer; Shanna Kim; Gary W Small; Joshua Chodosh; Johannes Czernin; Michael E Phelps
Journal:  J Nucl Med       Date:  2002-02       Impact factor: 10.057

6.  Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort.

Authors:  J A Luchsinger; M X Tang; Y Stern; S Shea; R Mayeux
Journal:  Am J Epidemiol       Date:  2001-10-01       Impact factor: 4.897

7.  The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function.

Authors:  H B Posner; M-X Tang; J Luchsinger; R Lantigua; Y Stern; R Mayeux
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

8.  Hyperinsulinemia and risk of Alzheimer disease.

Authors:  Jose A Luchsinger; Ming-Xin Tang; Steven Shea; Richard Mayeux
Journal:  Neurology       Date:  2004-10-12       Impact factor: 9.910

9.  Effects of white matter lesions and lacunes on cortical function.

Authors:  Bruce R Reed; Jamie L Eberling; Dan Mungas; Michael Weiner; Joel H Kramer; William J Jagust
Journal:  Arch Neurol       Date:  2004-10

10.  White matter changes compromise prefrontal cortex function in healthy elderly individuals.

Authors:  Christine Wu Nordahl; Charan Ranganath; Andrew P Yonelinas; Charles Decarli; Evan Fletcher; William J Jagust
Journal:  J Cogn Neurosci       Date:  2006-03       Impact factor: 3.225

View more
  16 in total

1.  Effect of leisure activities on inflammation and cognitive function in an aging sample.

Authors:  Feng Lin; Elliot Friedman; Jill Quinn; Ding-Geng Din Chen; Mark Mapstone
Journal:  Arch Gerontol Geriatr       Date:  2012-02-27       Impact factor: 3.250

2.  Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging.

Authors:  Eric M Reiman; Kewei Chen; Jessica B S Langbaum; Wendy Lee; Cole Reschke; Daniel Bandy; Gene E Alexander; Richard J Caselli
Journal:  Neuroimage       Date:  2009-07-23       Impact factor: 6.556

3.  Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study.

Authors:  David S Knopman; Michael E Griswold; Seth T Lirette; Rebecca F Gottesman; Kejal Kantarci; A Richey Sharrett; Clifford R Jack; Jonathan Graff-Radford; Andrea L C Schneider; B Gwen Windham; Laura H Coker; Marilyn S Albert; Thomas H Mosley
Journal:  Stroke       Date:  2015-01-06       Impact factor: 7.914

4.  Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.

Authors:  Laura D Baker; Donna J Cross; Satoshi Minoshima; Dana Belongia; G Stennis Watson; Suzanne Craft
Journal:  Arch Neurol       Date:  2010-09-13

5.  Cardiovascular risk in cognitively preserved elderlies is associated with glucose hypometabolism in the posterior cingulate cortex and precuneus regardless of brain atrophy and apolipoprotein gene variations.

Authors:  Jaqueline Hatsuko Tamashiro-Duran; Paula Squarzoni; Fábio Luís de Souza Duran; Pedro Kallas Curiati; Homero Pinto Vallada; Carlos Alberto Buchpiguel; Paulo Andrade Lotufo; Mauricio Wajngarten; Paulo Rossi Menezes; Márcia Scazufca; Tânia Corrêa de Toledo Ferraz Alves; Geraldo Filho Busatto
Journal:  Age (Dordr)       Date:  2012-04-29

6.  Baseline cardiovascular risk predicts subsequent changes in resting brain function.

Authors:  Lori L Beason-Held; Madhav Thambisetty; Gerard Deib; Jitka Sojkova; Bennett A Landman; Alan B Zonderman; Luigi Ferrucci; Michael A Kraut; Susan M Resnick
Journal:  Stroke       Date:  2012-04-05       Impact factor: 7.914

7.  Brain injury biomarkers are not dependent on β-amyloid in normal elderly.

Authors:  David S Knopman; Clifford R Jack; Heather J Wiste; Stephen D Weigand; Prashanthi Vemuri; Val J Lowe; Kejal Kantarci; Jeffrey L Gunter; Matthew L Senjem; Michelle M Mielke; Rosebud O Roberts; Bradley F Boeve; Ronald C Petersen
Journal:  Ann Neurol       Date:  2013-02-19       Impact factor: 10.422

Review 8.  Vulnerable neural systems and the borderland of brain aging and neurodegeneration.

Authors:  William Jagust
Journal:  Neuron       Date:  2013-01-23       Impact factor: 17.173

9.  Dissociable effects of Alzheimer disease and white matter hyperintensities on brain metabolism.

Authors:  Thaddeus J Haight; Susan M Landau; Owen Carmichael; Christopher Schwarz; Charles DeCarli; William J Jagust
Journal:  JAMA Neurol       Date:  2013-08       Impact factor: 18.302

10.  Effects of age, genes, and pulse pressure on executive functions in healthy adults.

Authors:  Naftali Raz; Cheryl L Dahle; Karen M Rodrigue; Kristen M Kennedy; Susan Land
Journal:  Neurobiol Aging       Date:  2009-06-25       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.